close
This ad will auto close in 10 seconds

Ranbaxy Q1 net loss narrows to Rs 185.92 cr

The company had posted a net loss of Rs 524.24 crore for the corresponding period of the previous fiscal, Ranbaxy Laboratories said in a statement.

Ranbaxy working with US regulators for Lipitor launch

Ranbaxy Laboratories Wednesday said it is still working with US regulators to remove the ban imposed on it so that it can sell generic version of cholesterol lowering drug Lipitor in the American market, though it has less than three weeks left for the start of its marketing exclusivity.

Ranbaxy Q3 net loss at Rs 464.58 crore

Drug major Ranbaxy Wednesday reported a net loss after tax and minority interest of Rs 464.58 crore for the quarter ended September 30, 2011, on account of foreign exchange losses.